PRESS RELEASE published on 07/18/2023 at 08:00, 2 years 10 months ago Defence Therapeutics Inc.: DEFENCE SUCCESSFULLY COMPLETES THE FIRST MILESTONE OF ITS COLLABORATION AGREEMENT WITH ORANO
PRESS RELEASE published on 07/04/2023 at 08:00, 2 years 11 months ago DEFENCE AND VIEWPOINT WITH DENNIS QUAID JOIN FORCES TO EXPLORE BREAKTHROUGHS IN BIOTECHNOLOGY
PRESS RELEASE published on 06/28/2023 at 17:21, 2 years 11 months ago Defence Therapeutics Inc.: DEFENCE PATENT PORTFOLIO AT THE FOREFRONT OF SUCCESS
PRESS RELEASE published on 06/20/2023 at 08:00, 2 years 11 months ago DEFENCE’S PROPRIETARY ACCUM(TM) TECHNOLOGY FOR DELIVERY OF CRISPR/CAS GENOME-EDITING COMPLEXES PATENT APPLICATON PUBLISHED
PRESS RELEASE published on 06/16/2023 at 08:00, 3 years ago DEFENCE MANUFACTURING OF ACCUTOXTM CGMP FINAL DRUG PRODUCT OPTIMIZATION FOR ITS PHASE I CLINICAL TRIAL AT CITY OF HOPE
PRESS RELEASE published on 06/06/2023 at 08:00, 3 years ago Defence Therapeutics Inc.: DEFENCE BEGINS TESTING ITS ARM VACCINE AGAINST PANCREATIC CANCER
PRESS RELEASE published on 05/24/2023 at 08:00, 3 years ago Defence Therapeutics Inc.: BREAKTHROUGH RESULTS: DEFENCE’S ARM VACCINE CURED 100% OF ANIMALS WITH PRE-ESTABLISHED LYMPHOMA
PRESS RELEASE published on 05/02/2023 at 08:00, 3 years 1 month ago Defence Therapeutics Inc.: DEFENCE’S SUCCESFULL ACCUTOXTM PRE-CLINICAL EFFICACY STUDY COMPLETE READY FOR PHASE I IND FILING
PRESS RELEASE published on 04/27/2023 at 08:00, 3 years 1 month ago Defence Therapeutics Inc.: USPTO GRANTS TRADEMARK REGISTRATION FOR DEFENCE THERAPEUTICS®
PRESS RELEASE published on 04/24/2023 at 08:00, 3 years 1 month ago Defence Therapeutics Inc.: DEFENCE GRANTED US PATENT WITH BROAD COVERAGE ON ACCUMTM-BASED VACCINE ENHANCER PLATFORM TECHNOLOGY
Published on 06/18/2026 at 00:00, 6 hours 59 minutes ago LIR Life Sciences Completes Comparative Animal Study Showing Successful Protamine-Enhanced Permeation Transport of Both Semaglutide and Tirzepatide
Published on 06/17/2026 at 23:30, 7 hours 29 minutes ago Polaris Renewable Energy Announces Postponement of Annual Meeting of Shareholders
Published on 06/17/2026 at 22:50, 8 hours 9 minutes ago International Battery Metals Ltd. Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results
Published on 06/17/2026 at 22:30, 8 hours 29 minutes ago Innodata Appoints Jayant Chauhan as Chief Financial Officer
Published on 06/17/2026 at 16:55, 14 hours 4 minutes ago Snipp Interactive Named a Representative Vendor in the Gartner(R) 2026 Market Guide for Loyalty Program Vendors
Published on 06/18/2026 at 06:40, 18 minutes ago APES 2026: 2,000+ Chinese Source Factories, One-Stop Direct Sourcing -Maximizing Buyer Margins
Published on 06/18/2026 at 06:30, 28 minutes ago Schindler Holding Ltd. increases ongoing share buyback program to up to CHF 700 million
Published on 06/18/2026 at 04:05, 2 hours 53 minutes ago Hisense Brings Smarter Home Experiences to Families During the FIFA World Cup 2026™
Published on 06/18/2026 at 02:45, 4 hours 13 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Update on APAC matter
Published on 06/17/2026 at 21:40, 9 hours 18 minutes ago Tinnitus Quest Builds Momentum with Oxford Research Study, New Funding Call, and Second Tinnitus Hackathon
Published on 06/17/2026 at 17:40, 13 hours 19 minutes ago Report on share repurchases from 10 to 16 June 2026
Published on 06/17/2026 at 08:45, 22 hours 14 minutes ago Air Liquide is awarded its largest-ever contract in Spain to care for 90,000 patients living with respiratory conditions at home
Published on 06/16/2026 at 11:44, 1 day 19 hours ago Guillemot Corporation S.A. | Weekly report share buyback from June 8 to June 12 2026
Published on 06/15/2026 at 23:00, 2 days 7 hours ago BIOPHYTIS ANNOUNCES THE TEMPORARY SUSPENSION OF THE TRADING OF ITS SHARES
Published on 06/15/2026 at 18:57, 2 days 12 hours ago Reporting on share buyback transactions carried out between June 8 and June 11, 2026
